NDC Code 71335-1837-7 - Bupropion Hydrochloride

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

Bupropion Hydrochloride bupropion hydrochloride TABLET, EXTENDED RELEASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BUPROPION HYDROCHLORIDE(UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31)	BUPROPION HYDROCHLORIDE	150 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE(UNII: ETJ7Z6XBU4)
HYDROXYPROPYL CELLULOSE, UNSPECIFIED(UNII: 9XZ8H6N6OH)
CYSTEINE HYDROCHLORIDE(UNII: ZT934N0X4W)
MAGNESIUM STEARATE(UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE(UNII: OP1R32D61U)
POLYETHYLENE GLYCOL 3350(UNII: G2M7P15E5P)
POLYVINYL ALCOHOL, UNSPECIFIED(UNII: 532B59J990)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
FD&C RED NO. 40(UNII: WZB9127XOA)
FD&C BLUE NO. 2(UNII: L06K8R7DQK)
TALC(UNII: 7SEV7J4R1U)
POVIDONE, UNSPECIFIED(UNII: FZ989GH94E)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:71335-1837-9	100 in 1 BOTTLE Type 0: Not a Combination Product	07/06/2022
2	NDC:71335-1837-1	60 in 1 BOTTLE Type 0: Not a Combination Product	05/05/2021
3	NDC:71335-1837-2	90 in 1 BOTTLE Type 0: Not a Combination Product	17/02/2022
4	NDC:71335-1837-3	30 in 1 BOTTLE Type 0: Not a Combination Product	26/04/2021
5	NDC:71335-1837-4	120 in 1 BOTTLE Type 0: Not a Combination Product	07/06/2022
6	NDC:71335-1837-5	45 in 1 BOTTLE Type 0: Not a Combination Product	07/06/2022
7	NDC:71335-1837-6	180 in 1 BOTTLE Type 0: Not a Combination Product	02/02/2022
8	NDC:71335-1837-7	28 in 1 BOTTLE Type 0: Not a Combination Product	07/06/2022
9	NDC:71335-1837-8	56 in 1 BOTTLE Type 0: Not a Combination Product	07/06/2022

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA211347	11/02/2020

LABELER - Bryant Ranch Prepack(171714327)

REGISTRANT - Bryant Ranch Prepack(171714327)

NDC 71335-1837-7
API & Excipient Details